Trials / Not Yet Recruiting
Not Yet RecruitingNCT07464119
A Clinical Study of iPSC-Derived Islet Cells for Diabetes Mellitus Therapy
A Single-Arm, Open-Label Clinical Study of iPSC-Derived Islet Cells for the Treatment of Diabetes Mellitus
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Peking University First Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a single-arm, open-label clinical trial designed to assess the safety and therapeutic efficacy of iPSC-derived islet cell infusion in patients with diabetes mellitus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | iPSC-derived islet cell | iPSC-derived islet cell infusion |
Timeline
- Start date
- 2026-03-16
- Primary completion
- 2028-12-31
- Completion
- 2033-12-31
- First posted
- 2026-03-11
- Last updated
- 2026-03-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07464119. Inclusion in this directory is not an endorsement.